Phapros Tbk PT (PEHA) - Net Assets

Latest as of June 2025: Rp395.57 Billion IDR ≈ $23.18 Million USD

Based on the latest financial reports, Phapros Tbk PT (PEHA) has net assets worth Rp395.57 Billion IDR (≈ $23.18 Million USD) as of June 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (Rp1.46 Trillion ≈ $85.42 Million USD) and total liabilities (Rp1.06 Trillion ≈ $62.24 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check PEHA asset resilience ratio to evaluate the company's liquid asset resilience ratio.

Key Net Assets Metrics

Metric	Value
Current Net Assets	Rp395.57 Billion
% of Total Assets	27.13%
Annual Growth Rate	1.14%
5-Year Change	-46.94%
10-Year Change	-12.59%
Growth Volatility	18.47

Phapros Tbk PT - Net Assets Trend (2011–2024)

This chart illustrates how Phapros Tbk PT's net assets have evolved over time, based on quarterly financial data. Also explore Phapros Tbk PT balance sheet assets for the complete picture of this company's asset base.

Annual Net Assets for Phapros Tbk PT (2011–2024)

The table below shows the annual net assets of Phapros Tbk PT from 2011 to 2024. For live valuation and market cap data, see Phapros Tbk PT stock valuation.

Year	Net Assets	Change
2024-12-31	Rp393.12 Billion ≈ $23.04 Million	-48.97%
2023-12-31	Rp770.33 Billion ≈ $45.14 Million	-0.19%
2022-12-31	Rp771.82 Billion ≈ $45.23 Million	+4.16%
2021-12-31	Rp740.98 Billion ≈ $43.42 Million	+0.01%
2020-12-31	Rp740.91 Billion ≈ $43.41 Million	-9.82%
2019-12-31	Rp821.61 Billion ≈ $48.14 Million	+4.03%
2018-12-31	Rp789.80 Billion ≈ $46.28 Million	+12.60%
2017-12-31	Rp701.39 Billion ≈ $41.10 Million	+12.75%
2016-12-31	Rp622.08 Billion ≈ $36.45 Million	+38.33%
2015-12-31	Rp449.72 Billion ≈ $26.35 Million	+10.16%
2014-12-31	Rp408.25 Billion ≈ $23.92 Million	+4.31%
2013-12-31	Rp391.40 Billion ≈ $22.93 Million	+4.20%
2012-12-31	Rp375.63 Billion ≈ $22.01 Million	+10.75%
2011-12-31	Rp339.17 Billion ≈ $19.87 Million	--

Equity Component Analysis

This analysis shows how different components contribute to Phapros Tbk PT's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

Retained earnings have decreased by 682.4% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (December 2024)

Component	Amount	Percentage
Common Stock	Rp84.00 Billion	22.12%
Other Comprehensive Income	Rp655.40 Billion	172.58%
Other Components	Rp17.14 Billion	4.51%
Total Equity	Rp379.75 Billion	100.00%

Phapros Tbk PT Competitors by Market Cap

The table below lists competitors of Phapros Tbk PT ranked by their market capitalization.

Company	Market Cap
Genmin Ltd AU:GEN	$14.68 Million
CADOGAN ENERGY SOLUTIONS F:CPD	$14.68 Million
Way 2 Vat Ltd AU:W2V	$14.69 Million
Samil Co.Ltd KQ:032280	$14.69 Million
West International AB ST:WPAY	$14.65 Million
Idomoo Ltd TA:IDMO	$14.65 Million
Cheetah Holdings Bhd KLSE:7209	$14.65 Million
In8bio Inc NASDAQ:INAB	$14.65 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Phapros Tbk PT's equity between the two most recent reporting periods.

Equity Growth Insights

From 2023 to 2024, total equity changed from 749,534,237,000 to 379,753,679,000, a change of -369,780,558,000 (-49.3%).
Net loss of 285,069,165,000 reduced equity.
Dividend payments of 78,623,000 reduced retained earnings.
Other comprehensive income increased equity by 12,960,476,000.
Other factors decreased equity by 97,593,246,000.

Equity Change Factors (2023 to 2024)

Factor	Impact	Contribution
Net Income	Rp-285.07 Billion	-75.07%
Dividends Paid	Rp78.62 Million	-0.02%
Other Comprehensive Income	Rp12.96 Billion	+3.41%
Other Changes	Rp-97.59 Billion	-25.7%
Total Change	Rp-	-49.33%

Book Value vs Market Value Analysis

This analysis compares Phapros Tbk PT's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Current price-to-book ratio: 0.66x
The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.

Historical Price-to-Book Ratios

Date	Book Value per Share	Market Price	P/B Ratio
2011-12-31	Rp403.77	Rp298.00	x
2012-12-31	Rp437.19	Rp298.00	x
2013-12-31	Rp455.92	Rp298.00	x
2014-12-31	Rp486.01	Rp298.00	x
2015-12-31	Rp535.38	Rp298.00	x
2016-12-31	Rp740.57	Rp298.00	x
2017-12-31	Rp834.99	Rp298.00	x
2018-12-31	Rp916.58	Rp298.00	x
2019-12-31	Rp952.99	Rp298.00	x
2020-12-31	Rp856.73	Rp298.00	x
2021-12-31	Rp856.53	Rp298.00	x
2022-12-31	Rp894.11	Rp298.00	x
2023-12-31	Rp892.30	Rp298.00	x
2024-12-31	Rp452.09	Rp298.00	x

Capital Efficiency Dashboard

This dashboard shows how efficiently Phapros Tbk PT utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

Current Return on Equity (ROE): -75.07%
The company may be facing challenges in efficiently utilizing shareholder equity.
DuPont Analysis Breakdown:
• Net Profit Margin: -38.28%
• Asset Turnover: 0.52x
• Equity Multiplier: 3.77x
Recent ROE (-75.07%) is below the historical average (5.25%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year	Return on Equity	Net Profit Margin	Asset Turnover	Equity Multiplier	Economic Value Added
2011	19.07%	13.75%	1.02x	1.36x	Rp30.78 Billion
2012	18.83%	13.06%	0.95x	1.52x	Rp32.44 Billion
2013	10.99%	8.07%	0.81x	1.68x	Rp3.81 Billion
2014	11.10%	7.84%	0.91x	1.56x	Rp4.50 Billion
2015	14.01%	9.12%	1.02x	1.51x	Rp18.04 Billion
2016	13.99%	10.66%	0.92x	1.42x	Rp24.79 Billion
2017	17.86%	12.50%	0.85x	1.68x	Rp55.13 Billion
2018	17.18%	12.93%	0.55x	2.43x	Rp55.31 Billion
2019	12.75%	9.23%	0.53x	2.62x	Rp21.98 Billion
2020	6.74%	4.94%	0.51x	2.66x	Rp-23.48 Billion
2021	1.54%	1.05%	0.57x	2.56x	Rp-60.88 Billion
2022	3.74%	2.40%	0.65x	2.41x	Rp-47.04 Billion
2023	0.80%	0.59%	0.57x	2.36x	Rp-68.99 Billion
2024	-75.07%	-38.28%	0.52x	3.77x	Rp-323.04 Billion

Industry Comparison

This section compares Phapros Tbk PT's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.

Industry Context

Industry: Drug Manufacturers - Specialty & Generic
Average net assets among peers: $633,200,842,814
Average return on equity (ROE) among peers: 50.42%

Peer Company Comparison

Company	Net Assets	Return on Equity	Debt-to-Equity	Market Cap
Phapros Tbk PT (PEHA)	Rp395.57 Billion	19.07%	2.69x	$14.67 Million
Darya-Varia Laboratoria Tbk (DVLA)	$507.85 Billion	13.94%	0.26x	$105.33 Million
Indofarma Tbk (INAF)	$298.72 Billion	0.71%	1.44x	$22.88 Million
Merck Tbk (MERK)	$518.28 Billion	224.46%	1.44x	$110.25 Million
Pyridam Farma Tbk (PYFA)	$62.14 Billion	2.30%	0.13x	$198.84 Million
Sido Muncul PT (SIDO)	$1.30 Trillion	29.70%	0.65x	$862.39 Million
Tempo Scan Pacific Tbk (TSPC)	$1.11 Trillion	31.40%	0.29x	$644.79 Million

About Phapros Tbk PT

JK:PEHA Indonesia Drug Manufacturers - Specialty & Generic

Market Cap

$14.67 Million

Rp250.32 Billion IDR

Market Cap Rank

#25910 Global

#582 in Indonesia

Share Price

Rp298.00

Change (1 day)

-0.67%

52-Week Range

Rp260.00 - Rp364.00

All Time High

Rp2996.89